1326
A. Gualandi et al.
SPECIAL TOPIC
MeOH (1 mL) a 0 °C. After 1 h, the reaction was quenched with
H2O (2 mL) and diluted with Et2O (10 mL). The organic layer was
separated and the aq layer extracted with Et2O (2 × 20 mL). The
combined organic layers were washed with H2O (10 mL), dried
over Na2SO4, and concentrated in vacuo. The residue was purified
by flash chromatography.
Yield: 0.041 g (92%); orange oil; dr 4.5:1 (anti/syn) (determined by
integration of the RCHO H NMR signals); ee (anti) = 95%, ee
1
(syn) = 97% [ees were determined by chiral HPLC (Daicel Chiral-
cel OD-H column: n-hexane–i-PrOH, 99:1 to 90:10 over 30 min,
flow rate = 0.50 mL/min, 30 °C, λ = 214, 254 nm)]; tR (anti) = 21.3
min (minor), 22.1 min (minor), tR (syn) = 25.0 min (major), 27.8
min (minor).
1H NMR (400 MHz, CDCl3): δ (anti) = 0.86 (d, J = 7.1 Hz, 3 H),
1.39 (s, 9 H), 1.54–1.77 (m, 4 H), 2.27–2.38 (m, 1 H), 2.73–2.81 (m,
1 H), 2.93 (s, 6 H), 3.58–3.70 (m, 2 H), 6.67 (d, J = 8.7 Hz, 2 H),
6.95 (d, J = 9.1 Hz, 2 H), 7.08 (br d, J = 7.5 Hz, 2 H), 7.17 (tt,
J = 5.9 Hz, J = 7.1 Hz, J = 8.3 Hz, 1 H), 7.30 (d, J = 4.5 Hz, 2 H),
9.61 (d, J = 3.5 Hz, 1 H).
1H NMR (400 MHz, CDCl3): δ (syn) = 0.88 (d, J = 7.1 Hz, 3 H),
1.39 (s, 9 H), 1.54–1.77 (m, 4 H), 2.44–2.56 (m, 1 H), 2.73–2.81 (m,
1 H), 2.93 (s, 6 H), 3.58–3.70 (m, 2 H), 6.67 (d, J = 8.7 Hz, 2 H),
6.98 (d, J = 8.7 Hz, 2 H), 7.08 (d, J = 7.5 Hz, 2 H), 7.17 (tt, J = 5.9
Hz, J = 7.1 Hz, J = 8.3 Hz, 1 H), 7.30 (d, J = 4.5 Hz, 2 H), 9.51 (d,
J = 2.4 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ (anti) = 12.1, 14.1, 22.7, 28.3 (3 C),
31.2, 40.7 (2 C), 45.1, 52.4, 77.2, 80.0, 112.7 (2 C), 125.9 (2 C),
128.6 (2 C), 128.8, 129.0 (2 C), 142.4, 149.4, 154.7, 205.4.
(S)-2-[(R/S)-1,3,3-Triphenylallyl]octanal (6a)
The title product was prepared according to the general procedure
A. The residue was purified by flash chromatography (cyclohex-
ane–Et2O, 7:3).
Yield: 0.036 g (90%); yellow oil; dr = 2:1 (syn/anti) (determined by
1
integration of the RCHO H NMR signals); ee (syn) = 90%, ee
(anti) = 75% [ees were determined by chiral HPLC after reduction
of the product with NaBH4 in MeOH (Daicel Chiralcel column IC:
n-hexane–i-PrOH, 99:1, flow rate = 0.50 mL/min, 30 °C, λ = 210,
254 nm)]; tR (syn) = 23.6 min (major), 19.2 min (minor), tR
(anti) = 17.2 min (major), 20.6 min (minor).
1H NMR (200 MHz, CDCl3): δ (syn) = 0.89 (t, J = 6.2 Hz, 3 H),
1.13–1.26 (m, 8 H), 1.62–1.65 (m, 2 H), 2.73–2.75 (m, 1 H), 3.75 (t,
J = 9.6 Hz, 1 H), 6.14 (d, J = 10.6 Hz, 1 H), 7.16–7.46 (m, 15 H),
9.34 (d, J = 4.0 Hz, 1 H).
1H NMR (200 MHz, CDCl3): δ (anti) = 0.89 (t, J = 6.2 Hz, 3 H),
1.13–1.26 (m, 8 H), 1.62–1.65 (m, 2 H), 2.73–2.75 (m, 1 H), 3.64 (t,
J = 9.6 Hz, 1 H), 6.26 (d, J = 11.2 Hz, 1 H), 7.16–7.46 (m, 15 H),
9.43 (d, J = 4.8 Hz, 1 H).
13C NMR (50 MHz, CDCl3): δ (syn/anti) = 14.0, 22.5, 26.9, 27.1,
27.4, 27.5, 28.9, 29.3, 31.4, 31.6, 45.9 (syn), 46.1 (anti), 57.8 (syn),
58.5 (anti), 126.7 (2 C), 127.2 (3 C), 127.4 (5 C), 127.8 (2 C), 127.9
(2 C), 128.1, 128.2 (3 C), 128.3 (4 C), 128.8 (4 C), 129.0, 129.3,
129.7 (4 C), 139.5 (2 C), 141.8 (4 C), 141.9 (2 C), 204.2 (syn), 204.5
(anti).
13C NMR (100 MHz, CDCl3): δ (syn) = 12.1, 14.1, 22.7, 28.3 (3 C),
31.2, 40.7 (2 C), 45.1, 52.4, 77.2, 80.0, 112.7 (2 C), 125.9 (2 C),
128.6 (2 C), 128.8, 129.0 (2 C), 142.4, 149.4, 154.7, 205.4.
ESI-MS: m/z (%) = 447.2 (100) [M + Na]+, 871.4 (18) [2 M + Na]+.
(R)-2-{(R/S)-1-[4-(Dimethylamino)phenyl]-4,4-diethoxybut-2-
yn-1-yl}octanal (14a)
The title product was prepared according to the general procedure
C. The product was isolated as the corresponding alcohol after re-
duction with NaBH4 (see Supporting Information for details). The
residue was purified by flash chromatography (cyclohexane–Et2O,
8:2).
HRMS: m/z [M]+ calcd for C29H32O: 396.24531; found: 396.24588.
(2R/S,3S)-3-[4-(Dimethylamino)phenyl]-2-methyl-3-(thiophen-
3-yl)propanal (10c)
The title product was prepared according to the general procedure
B. The residue was purified by flash chromatography (cyclohex-
ane–Et2O, 7:3).
Yield: 0.038 g (97%); yellow oil; dr = 2.6:1 (anti/syn) (determined
by integration of the RCHO 1H NMR signals); ee (anti) = 97%, ee
(syn) = 94% [ees were determined by chiral HPLC (Daicel Chiral-
cel column IC: hexane–i-PrOH, 95:5, flow rate = 0.50 mL/min,
40 °C, λ = 210, 254 nm)]; tR (anti) = 29.2 min (major), 23.9 min
(minor), tR (syn) = 30.5 min (major), 56.8 min (minor).
1H NMR (400 MHz, CDCl3): δ (anti) = 0.88 (t, J = 6.6 Hz, 3 H),
1.21–1.34 (m, 16 H), 1.83 (m, 1 H), 2.94 (s, 6 H), 3.57–3.66 (m, 3
H), 3.69–3.79 (m, 3 H), 3.82 (d, J = 5.7 Hz, 1 H), 5.33 (d, J = 1.6
Hz, 1 H), 6.69–6.71 (m, 2 H), 7.20–7.23 (m, 2 H), 9.69 (d, J = 3.4
Hz, 1 H).
Yield: 0.023 g (84%); colorless oil; dr = 2:1 (anti/syn) (determined
by integration of the RCHO 1H NMR signals); ee (anti) = 93%, ee
(syn) = 90% [ees were determined by chiral HPLC (Daicel Chiral-
cel column IA: n-hexane–i-PrOH, 99:1 to 90:10 over 30 min, flow
rate = 0.50 mL/min, 30 °C, λ = 210, 254 nm)]; tR (anti) = 21.7 min
(major), 24.3 min (minor), tR (syn) = 23.1 min (minor), 28.7 min
(major).
1H NMR (400 MHz, CDCl3): δ (syn) = 0.85 (t, J = 7.0 Hz, 3 H),
1.21–1.34 (m, 16 H), 1.83 (m, 1 H), 2.94 (s, 6 H), 3.57–3.66 (m, 3
H), 3.69–3.79 (m, 3 H), 3.93 (d, J = 6.3 Hz, 1 H), 5.34 (d, J = 1.6
Hz, 1 H), 6.69–6.71 (m, 2 H), 7.20–7.23 (m, 2 H), 9.65 (d, J = 3.1
Hz, 1 H).
13C NMR (50 MHz, CDCl3): δ (anti) = 14.1, 15.1 (2 C), 22.6, 27.2,
29.2, 29.5, 31.8, 38.4, 40.6 (2 C), 47.1, 60.7 (2 C), 63.3 (2 C), 86.7,
91.5, 112.6 (2 C), 127.2, 128.7 (2 C), 149.6.
1H NMR (400 MHz, CDCl3): δ (anti) = 1.02 (d, J = 6.8 Hz, 3 H),
2.94 (s, 6 H), 3.08–3.19 (m, 1 H), 4.32 (d, J = 10.2 Hz, 1 H), 6.66–
6.70 (m, 2 H), 6.89–6.96 (m, 2 H), 7.13 (d, J = 8.3 Hz, 1 H), 7.00–
7.18 (m, 2 H), 9.67 (d, J = 3.0 Hz, 1 H).
1H NMR (400 MHz, CDCl3): δ (syn) = 1.12 (d, J = 6.8 Hz, 3 H),
2.92 (s, 6 H), 3.08–3.19 (m, 1 H), 4.31 (d, J = 9.9 Hz, 1 H), 6.66–
6.70 (m, 2 H), 6.92–6.89 (m, 2 H), 7.06–7.18 (m, 3 H), 9.57 (d,
J = 2.9 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ (syn/anti) = 13.4 (anti), 13.5 (syn),
40.4 (2 C), 40.5 (2 C), 47.2, 48.0, 51.9 (syn), 52.0 (anti), 112.4,
112.6 (2 C), 112.7, 124.0 (2 C), 124.2, 126.5, 126.6, 128.6, 128.7 (2
C), 129.2 (anti), 129.3, 129.4 (syn), 132.7 (syn), 146.8 (syn), 147.1
(anti), 149.2 (syn), 149.5 (anti), 204.0 (syn), 204.1 (anti).
13C NMR (50 MHz, CDCl3): δ (syn) = 14.1, 15.1 (2 C), 22.6, 27.2,
29.2, 29.5, 31.8, 38.4, 40.6 (2 C), 47.1, 60.8 (2 C), 63.3 (2 C), 86.7,
91.5, 112.6 (2 C), 127.2, 128.7 (2 C), 149.6.
ESI-MS: m/z (%) = 390.2 (100) [M + H]+, 412.3 (21) [M + Na]+.
(R)-2-{(R/S)-5-[(tert-Butyldimethylsilyl)oxy]-1-[4-(dimethyl-
amino)phenyl]pent-2-yn-1-yl}octanal (14b)
ESI-MS: m/z (%) = 274.2 (100) [M + H]+.
The title product was prepared according to the general procedure
C. The residue was purified by flash chromatography (cyclohex-
ane–Et2O, 8:2).
tert-Butyl {(4S/R,5R)-4-[4-(Dimethylamino)phenyl]-5-methyl-
6-oxohexyl}(phenyl)carbamate (10g)
The title product was prepared according to the general procedure
B. The residue was purified by flash chromatography (cyclohex-
ane–Et2O, 8:2).
Yield: 0.042 g (94%); yellow oil; dr = 2.5:1 (anti/syn) (determined
by integration of the RCHO 1H NMR signals); ee (anti) = 98%, ee
Synthesis 2014, 46, 1321–1328
© Georg Thieme Verlag Stuttgart · New York